Koninklijke Philips (PHG) Net Income Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.48% |
| Dec 31, 2025 | -54.30% |
| Sep 30, 2025 | -14.99% |
| Jun 30, 2025 | -16.51% |
| Mar 31, 2025 | -17.71% |
| Dec 31, 2024 | -90.13% |
| Sep 30, 2024 | 50.05% |
| Jun 30, 2024 | 65.44% |
| Mar 31, 2024 | 16.06% |
| Dec 31, 2023 | 46.40% |
| Sep 30, 2023 | 47.80% |
| Jun 30, 2023 | 60.26% |
| Mar 31, 2023 | -15.86% |
| Dec 31, 2022 | -27.24% |
| Sep 30, 2022 | -71.01% |
| Jun 30, 2022 | -56.83% |
| Mar 31, 2022 | -33.87% |
| Dec 31, 2021 | 16.21% |
| Sep 30, 2021 | 42.46% |
| Jun 30, 2021 | -8.22% |
| Mar 31, 2021 | 27.17% |
| Dec 31, 2020 | -2.74% |
| Sep 30, 2020 | -9.95% |
| Jun 30, 2020 | -30.16% |
| Mar 31, 2020 | -9.80% |
| Dec 31, 2019 | -51.10% |
| Jun 30, 2018 | -102.00% |
| Mar 31, 2018 | 28.39% |
| Dec 31, 2017 | -8.06% |
| Sep 30, 2017 | 70.25% |
| Jun 30, 2017 | 40.84% |
| Mar 31, 2017 | 42.68% |
| Dec 31, 2016 | -60.73% |
| Sep 30, 2016 | 29.04% |
| Jun 30, 2016 | 21.04% |
| Mar 31, 2016 | 17.19% |
| Dec 31, 2015 | 39.08% |
| Sep 30, 2015 | 58.10% |
| Jun 30, 2015 | 27.05% |
| Mar 31, 2015 | 33.22% |
| Dec 31, 2014 | -22.55% |